Article info

This article has corrections. Please see:

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study
Free

Authors

  1. Correspondence to:
    Professor C J Hawkey, School of Medical and Surgical Sciences, Division of Gastroenterology, University Hospital, Nottingham NG7 2UH, UK;
    cj.hawkey{at}nottingham.ac.uk
View Full Text

Citation

Hawkey CJ, Laine L, Simon T on behalf of the Rofecoxib Rheumatoid Arthritis Endoscopy Study Group, et al
Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

Publication history

  • Accepted December 17, 2002
  • First published June 1, 2003.
Online issue publication 
June 01, 2003
  • Publisher Correction

    Please note that there is an error in the published version of the key in Figure 2.

    The correct key is shown here:

      Placebo
      Rofecoxib 50 mg
      Naproxen 500mg

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.